Hematologic Neoplasms Concept

subject area of

• A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy  Journal Articles
• A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology  Journal Articles
• A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets  Journal Articles
• A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets  Journal Articles
• A study of the agreement between patient self‐assessment and study personnel assessment of bleeding symptoms  Journal Articles
• Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial  Journal Articles
• Body mass index and thromboembolism in children with hematological malignancies  Journal Articles
• CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies  Journal Articles
• COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies  Journal Articles
• Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study  Journal Articles
• Capacity building for hematologic malignancies in Uganda: a comprehensive research, training, and care program through the Uganda Cancer Institute–Fred Hutchinson Cancer Research Center collaboration  Journal Articles
• Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016  Journal Articles
• Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation  Journal Articles
• Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable  Journal Articles
• Experience With Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome at a Single Institution  Journal Articles
• Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy  Journal Articles
• Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study  Journal Articles
• Financial toxicity in hematological malignancies: a systematic review  Journal Articles
• Global Approach to Hematologic Malignancies  Journal Articles
• Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care  Journal Articles
• Hemorrhagic Complications in Pediatric Hematologic Malignancies  Journal Articles
• Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD  Conferences
• Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients  Journal Articles
• How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.  Conferences
• Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis  Journal Articles
• Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (PROMs)  Journal Articles
• Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank  Journal Articles
• Influence of One Human Leukocyte Antigen Mismatch on Outcome of Allogeneic Bone Marrow Transplantation from Related Donors  Journal Articles
• Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers  Journal Articles
• Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial  Journal Articles
• Long-Term Survival after Blood and Marrow Transplantation: Comparison with an Age- and Gender-Matched Normative Population  Journal Articles
• Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation  Journal Articles
• Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study  Journal Articles
• Multimodality imaging in amyloidosis  Journal Articles
• NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD  Journal Articles
• Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies  Journal Articles
• Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature  Journal Articles
• Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease  Journal Articles
• Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies  Journal Articles
• Preface  Journal Articles
• Prevention of Thrombosis in Ambulatory Patients With Cancer  Journal Articles
• Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm  Journal Articles
• Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers  Journal Articles
• Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support  Journal Articles
• Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report  Journal Articles
• TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis  Journal Articles
• Telomeres and Telomerase in Normal and Malignant Haematologic Cells  Journal Articles
• The Nurse Practitioner Role in Complex Malignant Hematology: A Qualitative Descriptive Study  Journal Articles
• The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A Systematic Review  Conferences
• Thromboembolic Complications in Pediatric Hematologic Malignancies  Journal Articles
• Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute  Journal Articles
• Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review  Journal Articles